Established in Australia in 1992, Homart Pharmaceuticals has won many outstanding awards in the past 22 years. Lately, Homart has grown steadily and rapidly, and has won 15 Australian and International business awards during the past 5 years. Homart’s business strength and its contribution towards the economy in Australia are widely recognized, and Homart Pharmaceuticals was recommended to Chung-Hua Institution for Economic Research (CIER) for an interview by Australia Trade Commission (Austrade) Offices in Taiwan, as a distinguished Australian enterprise.
The Chung-Hua Institution for Economic Research (CIER) is an economic research organization in Taiwan, and was founded on July 1st, 1981. CIER not only researches on global, Taiwanese, and mainland Chinese Economy, but also on economic models and economic forecasting, on WTO (World Trade Organization) issues, handling WTO matters, promotion, personnel training and database building, on energy and environment related economic issues, on regional economic integration trends and on FTA-related (Free Trade Agreement) issues ; research, policy consultation, academic exchange and publication on topics related to ASEAN (Association of Southeast Asia Nations) and Asian regional development in economics and trade. They also hold lifetime-learning classes and organize academic conferences, in keeping with the needs of the times. CIER also publishes books, periodic papers, and research projects. This interview with Homart Pharmaceuticals on its culture and operations philosophy no doubt would help other businesses foresee success in operating their enterprises after the FTA (Free Trade Agreement) between Australia and Taiwan in the near future.
Ms. Ying-Hua KU, Director/Fellow Researcher, together with Ms. Mei-Yin KING, analyst, of Regional Development Study Centre in CIER (their research is on International Trade & Investment, and in Regional Economic Integration), made their visit to Homart Pharmaceuticals’ Rydalmere head office. With the accompaniment of Homart’s Operations Director- Mr. Jeffery, CIER officers visited the showroom, conference areas, cGMP manufactory area, activity centre, dining room and Homart museum, the hundred-year-old historical site located in the beautiful natural reserve. Our strict quality control and natural factory environment made a deep impression on our valuable visitors. During this interview, Homart Pharmaceuticals was highly praised for our successful achievements, excellent performance, high reputation in this industry and top quality products. Homart Pharmaceuticals was the exclusive health supplement retail manufacturer in EXPO 2010 Shanghai China. Homart also achieved an overwhelming 850% growth in sales within the past 5 years, an increase at a growth rate of more than 25% each year in the past five years, an amazingly high market share of 70% of the health food export market in Macau, growing several times over in turnover, sales and staff in the next two years was foreseeable.
Homart’s goal is to manufacture and distribute high quality Australian made health supplements, skin care products and infant formula. In hopes to bring a healthy, balanced and happy life to the general public, Homart has been working very hard on that for the past 22 years. Homart Pharmaceuticals really is a model of Australian business which successfully established a high quality cGMP pharmaceutical factory and company in the pristine environment under strict pharmaceutical standards. Homart and CIER are hoping to see the FTA in between Australia and Taiwan signed in the near future. Homart is always your first choice!
Homart Pharmaceuticals’ phone: 02-9648 2880, website: www.homart.com.au
Photo: Chung-Hua Institution for Economic Research visits Homart Pharmaceuticals, welcomed by Homart’s Managing Director-Ms. Lynn YEH, & Operations Director- Mr. Jeffrey